| SHORT COMMUNICATION |
|
| Year : 2009 | Volume
: 41
| Issue : 6 | Page : 286-287 |
Gynecomastia: An ADR due to drug interaction
Umme Aiman1, MA Haseeen2, SZ Rahman1
1 Department of Pharmacology, Jawaharlal Nehru Medical College, AMU, Aligarh, India
2 Department of Cardio-Vascular and Thoracic Surgery, Safdarjang Hospital, New Delhi, India
Correspondence Address:
S Z Rahman
Department of Pharmacology, Jawaharlal Nehru Medical College, AMU, Aligarh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.59929
Gynecomastia results from conditions that cause an imbalance of estrogenic and androgenic effects on the breast, resulting in an increased or unopposed estrogen action on breast tissue. Approximately 4 to 10% cases of gynecomastia are due to drugs. Both Digoxin and Furosemide are also reported to cause the same condition. Although, chances of gynecomastia could be more if these two drugs are coadministered, but no case report of this adverse effect is ever reported when both are prescribed concurrently. Here we report a case of gynecomastia suspected to have resulted from the coadministation of both the drugs. Probability of the adverse effect due to drug interaction was evaluated by DIPS, which suggests that the adverse drug reaction (ADR) due to DI is "Possible."
[FULL TEXT] [PDF]*
|
